Placeholder

LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

Travera

Travera is using a breakthrough technology to measure which cancer drugs work against each individual’s unique cancer cells.  We are developing a universal biomarker for enabling oncologists to quickly determine which drugs to prescribe based on the actual responses of their patients’ tumor cells to candidate drugs.

Travera logo
Website - Coming Soon
  • Clifford A. Reid, PhD Co-Founder and CEO
  • Professor Scott Manalis Co-Founder and Consultant
  • Rob Kimmerling, PhD Co-founder and Director of Research and Development
  • Selim Olcum, PhD Co-Founder and Director of Engineering
  • Mark Stevens, PhD Co-Founder and Director of Clinical Development